N/A
Completed N=321
The MSK-Tracker Study
Source: ClinicalTrials.gov NCT03559205 ↗Enrolled (actual)
321
Serious AEs
0.0%
Results posted
Nov 2021
Primary outcomePrimary: Patient Enablement Instrument (PEI) — 1.48; 1.50 units on a scale — p=0.96
Summary
This study will co-design and test the feasibility and impact of implementing the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) using an e-PROM (electronic Patient Reported Outcome Measure) delivered via a digital health platform, with innovative embedded components called the MSK-Tracker. The MSK-Tracker uses the MSK-HQ as a foundation to help patients with MSK pain to:
* track the extent to which they are affected by their MSK condition across different aspects of their health,
* prepare appropriately for their clinical encounters, and
* take the right steps to making positive changes to improve their quality of life and manage their condition over the longer-term.
The Study Aims to:
1. Test the ability of the MSK-Tracker to act as an empowerment tool and method of facilitating a person-centred care planning approach in routine MSK clinic consultations.
2. Assess the value of the MSK-Tracker in generating aggregated outputs that inform MSK service improvement.
Study Design This study will use a before and after single Centre design with the comparator between phases 1 and 3 across a range of outcomes. Phase 2 will focus on iterative testing of the MSK-Tracker.
In addition, in Phase 1 and 3 will include qualitative research (site 1 only) using the Experience Based Co-Design (EBCD) methodology to explore the impact of the MSK-Tracker and to inform further improvement and refinement of the tool and its use within the context of an MSK service and clinical practice. The findings from the qualitative research will be triangulated with insights from the aggregated data of patient outcomes to enrich and help make sense of the study findings.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Enablement Instrument (PEI) |
1.48; 1.50 | 0.96 |
| SECONDARY Musculoskeletal Health Questionnaire (MSK-HQ) |
24.32; 24.45; 26.63; 24.62; 27.17; 26.23 | 0.90 |
| SECONDARY Consumer Health Activation Index (CHAI) |
71.42; 68.79; 73.24; 71.03; 72.72; 72.14 | 0.15 |
| SECONDARY Valuing Patients as Individuals Scale (Short Version) |
13.1; 12.99; 12.71; 12.49 | 0.72 |
| SECONDARY Global Rating of Change (1 Item) |
2.91; 2.71; 2.98; 2.82 | 0.30 |
| SECONDARY The Patient Enablement Scale |
1.82; 2.12 | 0.61 |
Eligibility Criteria
Inclusion Criteria
- Patients aged 18 years and above with an appointment to attend the Staffordshire Musculoskeletal Interface Service for an MSK pain problem will be invited to take part.
Exclusion Criteria
- Patients unable to use or access the internet will be unable to take part in this research as well as patients who do not provide informed consent for study participation and data collection. The online system will only be available in English.
Data sourced from ClinicalTrials.gov (NCT03559205). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.